Profile

Dr. Ecaterina Scarlatescu

Fundeni Clinical Institute

Contact Details

Fundeni Clinical Institute
Romania

To review payment history, update your contact details, password or full profile information, please click here to visit our secure database in a new window.

Note: editing some of these profiles fields or renewing your membership will take you to a new window. The ISTH uses a separate and secure database for some data and payment processing. When finished updating, you can return to the previous window or revisit my.isth.org.

Bio

I graduated from the University of Medicine and Pharmacy Carol Davila of Bucharest in 2005 and I am appointed as consultant in the Department of Anaesthesiology and Intensive Care III at Fundeni Clinical Institute. I am involved in clinical work (visceral and thoracic surgery, liver transplantation, care of the medical and surgical intensive care patients- both adults and pediatric patients), but also in research and training activities. 
 I received the RTW Fellowship from the International Society on Hemostasis and Thrombosis in 2017, and trained for three months at Maastricht University Medical Center in Maastricht, the Netherlands on the topics of the anticoagulant management in patients on extracorporeal life support and the use of thrombin generation tests. In 2018 I completed my PhD with the thesis “The complex assessment of coagulation disturbances in early sepsis and their prognostic significance”. Since 2018 I served as a Co-Chair in the DIC Subcommittee of the International Society on Hemostasis and Thrombosis (ISTH) and in 2020 I was appointed Chair of the DIC Subcommittee. Since 2018 I received 2 research grants from ISTH for the study of coagulopathy in septic patients and DIC in cirrhotic patients. 
Major research interests and current research projects include: the study of sepsis associated coagulopathy and sepsis induced DIC, the assessment of hemostasis in acute liver failure and end stage liver diseases, the assessment of coagulopathy in cirrhotic patients with sepsis and septic shock, bleeding management in liver transplantation , antithrombotic therapy monitoring in liver cirrhosis patients, extracorporeal blood purification therapies for supportive treatment of acute liver failure patients and as bridging to liver transplantation, the diagnostic and clinical implications of cirrhotic cardiomyopathy and postreperfusion syndrome during liver transplantation.